Clinical efficacy of Vortioxetine vs Escitalopram in depressive disorder
Not Applicable
- Conditions
- Health Condition 1: F32- Major depressive disorder, singleepisode
- Registration Number
- CTRI/2022/07/043662
- Lead Sponsor
- Ahana Hospitals LLP
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients who are meeting International Classification of Diseases 10 criteria for major depressive disorder
Patients who gave informed written consent.
Exclusion Criteria
Patients with other comorbid psychiatric disorder (except major depressive disorder)
Patients who were having comorbid substance
dependence
Patients with any other medical disorder which is
confounding our inclusion diagnosis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 17-item Hamilton Depression Scale (HAM-D17) done at baseline, 2nd week, 4th week and 12th weeksTimepoint: 17-item Hamilton Depression Scale (HAM-D17) done at baseline, 2nd week, 4th week and 12th weeks
- Secondary Outcome Measures
Name Time Method CGI- severity of illness (CGI-S) and improvement scale (CGI-I) done at baseline, 2nd week, 4th week and 12th weekTimepoint: CGI- severity of illness (CGI-S) and improvement scale (CGI-I) done at baseline, 2nd week, 4th week and 12th week